Related by context. All words. (Click for frequent words.) 73 IV APAP 73 Acetavance 72 Omigard TM 72 CLIRS trial 71 Zelrix 71 OFIRMEV 71 rhThrombin 70 Veronate 69 PREOS R 69 Iluvien ® 68 oral ridaforolimus 68 Dyloject TM 68 OvaRex ® MAb 68 intravenous acetaminophen 68 T Pred 68 Ketotransdel 67 IV acetaminophen 67 phase IIb clinical 67 ZEGERID Capsules 67 Acetavance TM 67 Biologic License Application BLA 67 Fodosine 67 StaphVAX R 67 oxymorphone ER 67 lucinactant 67 BLA submission 67 faropenem 67 CIP ISOTRETINOIN 67 alvimopan 67 Cleviprex TM clevidipine 67 Civacir 66 Allovectin 7 66 Xcytrin R 66 PLK1 SNALP 66 Cellegesic 66 SinuNase TM 66 FOLOTYN ® 66 CoFactor 66 FROVA 66 StaphVAX 66 EFAPROXYN 66 TELCYTA 66 Troxatyl 66 MyVax personalized immunotherapy 66 Mepact 66 TOCOSOL Paclitaxel 66 Anturol ® 66 Aurexis 66 Generx TM 66 elotuzumab 66 Corlux 66 Phase IIb clinical trials 66 acyclovir Lauriad R 66 MyVax R 66 PANVAC VF 66 BLA filing 65 pradefovir 65 SUPPRELIN R LA 65 UPLYSO 65 Exelbine 65 RANK Ligand inhibitor 65 OMNARIS Nasal Spray 65 VALSTAR 65 opioid induced bowel dysfunction 65 faropenem medoxomil 65 delivers fluocinolone acetonide FA 65 phase IIa clinical 65 oxypurinol 65 Viramidine 65 ruxolitinib 65 SILENOR 65 Phase III clinical 65 IND submission 65 CRMD# 65 Ofirmev 65 Frova ® 65 phase IIb trial 65 Topical Interferon Alpha 2b 65 ILUVIEN ® 65 Insegia 65 Besivance 65 balsalazide tablet 65 TELINTRA 65 Soliris TM eculizumab 65 Phenoptin 65 Stedivaze 65 confirmatory Phase III 65 ONTAK 65 CINTREDEKIN BESUDOTOX 65 Onco TCS 65 Anturol TM 65 SILENOR TM 65 dirucotide 65 HepeX B 65 Biologics License Application BLA 65 Ixempra 65 EVIZON TM squalamine lactate 65 lomitapide 65 Ereska 65 Neo Urinary Conduit 65 NEUPOGEN 65 IoGen 65 Velac 65 oral prodrug 64 Phase 2b clinical 64 Icatibant 64 RSR# 64 miconazole Lauriad ® 64 THALOMID 64 Tavocept 64 Zenvia ™ 64 Zemiva TM 64 cangrelor 64 SinuNase 64 reslizumab 64 RSD# oral 64 methylnaltrexone bromide 64 EOquin 64 targeted radiotherapeutic 64 ALN PCS 64 CIP TRAMADOL ER 64 forodesine 64 Q#IR 64 treat dysmenorrhea 64 Personalized Immunotherapy 64 Itopride 64 candidate epratuzumab 64 MAGE A3 ASCI 64 bicifadine 64 FavId 64 Zingo TM 64 successfully commercialize Iluvien 64 Filgrastim 64 talactoferrin 64 MyVax ® 64 Augment Bone Graft 64 aerosolized AAT 64 Tarsa oral calcitonin 64 IV Busulfex 64 granulated mesalamine 64 Cardio Vascu Grow 64 Increlex TM 64 EOquin TM 64 AzaSite Plus 64 proprietary transdermal patch 64 MAXY G# 64 Amoxicillin PULSYS 64 assessing T DM1 64 PREOS 64 Soliris eculizumab 64 Theratope 64 Fibrillex TM 64 LEP ETU 64 Phase IIa trials 64 investigational pan BCR 64 ENTEREG ® 64 Zerenex 64 FACTIVE R gemifloxacin 64 Surfaxin LS 64 JOULFERON 64 TLK# 64 Augment Injectable 64 Solazed 64 Initiate Clinical Trial 64 systemic immunosuppressive drugs 64 BiovaxID TM 64 Vascular Wrap TM 64 PDX pralatrexate 64 selective androgen receptor modulator 64 SUPPRELIN LA 64 VISICOL R 63 Fibrin Pad 63 dextofisopam 63 custirsen 63 L BLP# 63 liprotamase 63 Bezielle 63 investigational antiplatelet agent 63 GALNS 63 Specifid 63 vernakalant iv 63 ecallantide 63 Canvaxin 63 Frova R 63 molecular imaging radiopharmaceutical 63 PrevOnco 63 vosaroxin 63 POSIDUR TM 63 phase IIb study 63 Orapred ODT 63 IMA# 63 virus HCV protease inhibitor 63 Drug Eluting Stent System 63 vernakalant oral 63 Amrubicin 63 ponatinib 63 PREGNANT Study 63 celgosivir 63 IRX 2 63 MOZOBIL 63 cinacalcet HCl 63 AzaSite TM 63 APF# 63 forodesine hydrochloride 63 MYDICAR 63 Cimzia TM 63 Phase 2a clinical trials 63 TOCOSOL Camptothecin 63 ACAPODENE TM 63 vaginally administered lidocaine 63 Dextofisopam 63 Folotyn 63 omacetaxine mepesuccinate 63 ORENCIA ® 63 ATryn ® 63 Biologics License Application 63 Proxinium TM 63 DPX Survivac 63 ENRICH trial 63 catheter occlusion 63 Generx ™ 63 pivotal Phase III 63 candidate XP# 63 lumiliximab 63 Prosaptide 63 KNS # 63 Vascular Wrap 63 Shigamabs R 63 GEM OS2 63 nalbuphine ER 63 eprodisate KIACTA TM 63 UVIDEM 63 PF # [002] 63 Xcellerated T Cells 63 Enjuvia 63 omiganan 63 Relivar 63 OvaRex R 63 Linjeta TM 63 Phase III clinical trials 63 midstage trials 63 OMS#HP 63 Actimmune ® 63 SEPET TM 63 Phase IIIb clinical 63 Alzhemed TM 63 DR Cysteamine 63 Phase III Pivotal 63 Dacogen injection 63 Aloxi Injection 63 zolpidem tartrate sublingual tablet 63 RIGScan CR 63 BEMA Granisetron 63 Nexavar sorafenib 63 Phase 2b study 63 Fx #A 63 candidate TNFerade biologic 63 drug eluting coronary stent 63 Excellarate TM 63 Urocidin 63 JAK inhibitor 63 AERx ® 63 acetonide FA 62 teduglutide 62 Ventavis 62 Vicinium TM 62 VersaFilm 62 Rhucin ® 62 EmbraceAC 62 Elagolix 62 overactive bladder AA# 62 Polymer Microspheres 62 SNT MC# 62 PNP inhibitor 62 Plenaxis TM 62 JZP 62 Shigamabs ® 62 QNEXA ® 62 Aloxi injection 62 Marqibo 62 Application BLA 62 Cutanea Life Sciences 62 Entereg alvimopan 62 Xolegel 62 Emezine 62 Proquin XR 62 Actimmune R 62 incyclinide 62 oral calcitonin 62 MYDICAR ® 62 valopicitabine 62 dacetuzumab 62 Octreolin 62 candidate Zenvia 62 phase III isavuconazole 62 Sulonex 62 Targretin capsules 62 Anturol 62 AQ4N 62 Levoleucovorin 62 candidate REP# 62 Loramyc R 62 Pruvel 62 brand ciclesonide HFA 62 Prestara 62 CAPHOSOL R 62 NEBIDO 62 Oracea TM 62 budesonide foam 62 Mycograb 62 Virulizin R 62 ridaforolimus 62 Tocosol Paclitaxel 62 Somatuline R Autogel R 62 QuadraSphere 62 vinorelbine emulsion 62 Fortical R 62 elagolix 62 TBC# 62 supplemental biologics 62 Phase #b/#a 62 HZT 62 Dendreon investigational 62 Neuromodulation System 62 thymalfasin 62 Voraxaze 62 Stimuvax R 62 rALLy clinical trial 62 alvespimycin 62 Entereg R 62 GED aPC 62 Phase #b/#a trial 62 Azedra TM 62 registrational trial 62 registrational 62 Premarket Approval Application 62 Lamictal ODT 62 Nasulin 62 dalbavancin 62 otelixizumab 62 sNDA filing 62 Spiegelmer ® 62 BEMA TM Fentanyl 62 Ceplene TM 62 MAA submission 62 Cangrelor 62 maribavir 62 GEM #S 62 initiated Phase Ib 62 Luramist 62 Onalta 62 R#/MEM # 62 TELINTRA R 62 INKP 62 ApoB SNALP 62 RELOVAIR ™ 62 highly purified pasteurized 62 miconazole Lauriad R 62 interferon gamma 1b 62 rNAPc2 62 refractory gout 62 PROVENGE ® 62 Asentar 62 CB2 selective receptor agonist 62 apaziquone 62 Phase 2a trial 62 BrachySil 62 aldehyde dehydrogenase ALDH2 deficiency 62 Neo Kidney Augment 62 ESTRASORB 62 Unit Dose Budesonide 62 Loramyc 62 Phase IIb clinical 62 Kynapid 62 Pivotal Phase III 62 PDE4 inhibitor 62 oral methylnaltrexone 62 lintuzumab SGN 62 confirmatory Phase 3 62 novel L DOS# 62 pseudobulbar affect PBA 62 Entereg TM 62 R sorafenib tablets 62 Nasdaq PGNX today 62 tafamidis 62 octreotide implant 62 LidoPAIN SP 62 Camvia 62 Neurodex 62 Phase 1b clinical 62 L MTP PE 62 HepaGam B 62 OncoVEX 62 SUCCEED trial 62 Aganocide 62 Moxatag 62 pralatrexate 62 Raptiva R 62 FACTIVE tablets 62 Surfaxin lucinactant 62 Evoltra ® 62 Zensana 62 PROMACTA 61 inhaled liposomal ciprofloxacin 61 phase IIb 61 ESTRASORB R 61 Argatroban 61 R sipuleucel T 61 RECOTHROM R 61 QNEXA 61 Myocet 61 RSD# iv 61 OncoVEX GM CSF 61 ALVESCO ® 61 Duromist ™ 61 oral salmon calcitonin 61 PRECISE Trial 61 Inhalation Solution 61 Intermezzo R 61 Ethyol 61 ONGLYZA ™ 61 Leukine 61 severe hypercholesterolemia 61 Junovan 61 TRISENOX ® 61 Cinryze ™ 61 casopitant 61 orBec 61 Ecallantide 61 MOVIPREP R 61 anidulafungin 61 Aryx 61 Probuphine 61 ABILIFY R 61 CIMZIA TM 61 Bicifadine 61 sodium Injection 61 IL# PE#QQR 61 sumatriptan DosePro 61 tolevamer 61 drug ISA# 61 PROMUS Element Stent 61 vinflunine 61 ZOLINZA 61 ONCONASE R 61 Sular formulation 61 CONBRIZA 61 Cotavance 61 TKM ApoB 61 IIa trial 61 XAGRID 61 SEBIVO 61 Genasense ® oblimersen 61 Xyfid TM 61 recombinant biopharmaceutical 61 Menerba 61 inhaled AAT 61 Proellex TM 61 Phase #b/#a clinical 61 DPP4 inhibitor 61 KRYSTEXXA 61 Onalta ™ 61 Allovectin 7 R 61 torezolid phosphate 61 Evamist TM 61 NV1FGF 61 EVIZON ™ 61 Firazyr 61 Empatic ™ 61 rThrombin 61 fidaxomicin 61 Pivotal Phase 61 Phase III Clinical Trial 61 Tarceva TM 61 XP# XP# 61 nasal calcitonin product 61 ORENCIA R 61 Rotarix ® 61 Urokinase 61 OLEPTRO 61 Velcade bortezomib 61 pegloticase 61 SinuNase ™ 61 NPSP# 61 ELADUR 61 Rhucin ® recombinant 61 TRANSDUR Sufentanil 61 AGGRASTAT ® 61 PRT# 61 phase IIa 61 SYCREST 61 ZYFLO 61 KYNAPID 61 vaginal lidocaine 61 novel histone deacetylase 61 hoFH 61 DexaSite 61 AEG# 61 treat chronic sinusitis 61 indiplon capsules 61 BRILINTA 61 investigational hepatitis B 61 dose cohort 61 Raptiva ® 61 Azedra 61 MT# MEDI 61 ZALBIN 61 PROVENGE sipuleucel T 61 Egrifta 61 ARCALYST ® 61 Hedgehog antagonist 61 LibiGel ® 61 Zemiva ™ 61 Panzem R 61 Phase 2b clinical trials 61 Intermezzo ® zolpidem tartrate 61 Pennsaid R 61 ularitide 61 Phase Ib study 61 Nabi HB Intravenous 61 generation purine nucleoside 61 telaprevir VX 61 Luveniq 61 Kosan dependence 61 Zensana TM 61 Shire BioChem Inc. 61 Aerosurf 61 plasma kallikrein inhibitor 61 histamine dihydrochloride 61 EDEMA3 61 LEVADEX ™ 61 Evoltra 61 Phase 2a clinical 61 NDA Submission 61 Excellagen 61 SPARLON 61 budesonide inhalation suspension 61 Dyloject 61 KRYSTEXXA TM pegloticase 61 Prednisporin TM 61 MelaFind R 61 multicenter Phase 61 Ozarelix 61 Troxatyl TM 61 metastatic sarcomas 61 HspE7 61 PhosLo 61 Preos 61 TRANSDUR Bupivacaine 61 aflibercept 61 trastuzumab DM1 T DM1 61 non nucleoside inhibitor 61 amrubicin 61 MoxDuo IR 61 prGCD 61 LymphoStat B TM 61 Oracea 61 investigational monoclonal antibody 61 Canvaxin TM 61 AERx iDMS 61 Phase IIa trial 61 Rhucin R 61 relapsed multiple myeloma 61 Nicotine Conjugate Vaccine 61 topically applied SEPA 61 Cloretazine ® 61 refractory angina 61 LymphoStat B belimumab 61 REG1 Anticoagulation System 61 Panzem R NCD 61 Phase IIa clinical trials 61 Marketing Authorisation Application 61 pegylated interferon alpha 61 OMS# 61 Silenor ® doxepin 61 Xibrom QD 61 % uracil topical 61 Jevtana 61 Initiates Enrollment 61 Phase IIB 61 Meets Primary Endpoint 61 TYZEKA 61 regorafenib 61 Aurograb 61 FUSILEV 61 Flutiform TM 61 Evoltra TM 60 Study GL# 60 BST CarGel R 60 cystinosis patients 60 Hematide ™ 60 Increlex ® 60 Pegloticase 60 SUMAVEL 60 eltrombopag 60 Kepivance 60 TAXUS Element Stent System 60 OvaRex 60 FUSILEV ® 60 Androxal TM 60 Lymphoseek ® 60 Locteron ® 60 Trizytek 60 Allovectin 7 r 60 Panzem 60 Puricase 60 ICA # 60 topical anti infective 60 Aflibercept 60 SANVAR 60 Stavzor 60 TYGACIL 60 Phase III trials 60 evaluating T DM1 60 CIMZIA TM certolizumab pegol 60 Capesaris 60 SPL# Gel vaginal microbicide 60 E2F Decoy 60 ADVEXIN clinical 60 sevelamer carbonate 60 Retavase 60 miconazole MBT 60 AVASTIN 60 Factor VIIa 60 Ozurdex 60 Intermezzo ® 60 Noxafil 60 Protexia R 60 NDA submission 60 Riquent 60 ELIQUIS 60 Cloretazine 60 BrachySil TM 60 docetaxel Taxotere R 60 Phase IIb trials 60 IONSYS TM 60 dermaPACE TM 60 Zelapar 60 pexelizumab 60 punctal plug 60 PEG PAL 60 RAPTIVA R 60 investigational pharmacologically unique 60 Rhucin 60 PrevOnco ™ 60 Ferumoxytol 60 INT# [002] 60 inhaled formulation 60 Actemra tocilizumab 60 liver resection surgeries 60 mesylate tablets 60 sitaxsentan 60 Istalol 60 investigational humanized monoclonal antibody 60 Fentanyl TAIFUN R 60 HEPLISAV TM 60 ISO Vorin TM 60 tiapamil 60 Vernakalant 60 initiate Phase 1b 60 LEUKINE 60 mertansine 60 Phase III pivotal 60 XIENCE V stent 60 PROMACTA ® 60 Sulonex TM 60 personalized immunotherapy 60 ZEGERID Powder 60 Hematide ™ peginesatide 60 Toremifene 60 Fentanyl Taifun 60 orBec R 60 Esbriet pirfenidone 60 baminercept 60 voclosporin 60 ezogabine 60 Fortigel 60 Cinryze TM 60 oncolytic virus therapies 60 VIAtab TM 60 DIFICID 60 Saforis 60 BioGlue R 60 oral rivaroxaban 60 metoprolol succinate 60 RhuDex ® 60 5 lipoxygenase inhibitor 60 Anthim 60 MONOVISC 60 Clolar ® 60 Glumetza TM 60 diclofenac sodium 60 dorzolamide 60 antibody MAb 60 INTEGRILIN ® 60 NADiA ProsVue 60 NUVIGIL 60 midstage studies 60 TAXUS TM 60 ENTEREG 60 AGGRASTAT R 60 ITAX 60 Zyflo 60 RELISTOR ® 60 SPRYCEL ® 60 HCD# [002] 60 Trofex TM 60 oxybutynin ATD TM 60 Glypromate 60 Archexin 60 treat male hypogonadism 60 induced macular edema 60 glufosfamide 60 REMOXY R 60 herpetic keratitis 60 EvaMist TM 60 intranasal formulation 60 POSIDUR TM ELADUR TM 60 AeroLEF TM 60 treat opioid induced 60 subcutaneous formulation 60 progesterone gel 60 naronapride 60 Kamada AAT 60 application sNDA 60 Ophena 60 VIAject R 60 Phase lll 60 MAXY alpha 60 BCX# 60 Aryplase 60 Vancocin R 60 Augment ™ 60 lapatinib Tykerb 60 Matrix Phase 2b 60 EndoTAG TM -1 60 HEPLISAV ™ 60 Pivotal Trial 60 ELACYT 60 PRECISE trial 60 XOMA 3AB 60 Ophena TM 60 Oracea R 60 ibuprofen Injection 60 MIST II 60 LUNESTA TM 60 Ostarine 60 Empatic 60 neurogenic orthostatic hypotension 60 HYVISC R 60 Intermezzo ® NDA 60 Complete Response 60 Vectibix panitumumab 60 including eniluracil ADH 60 proprietary intravenous formulation 60 Cethrin R 60 ALGRX 60 dextromethorphan quinidine 60 Achieves Primary Endpoint 60 ARCOXIA 60 Trobalt 60 APEX PD 60 Degarelix 60 glucokinase activator 60 ROTATEQ 60 Cutanea 60 Eligard R 60 VNP#M 60 sNDAs 60 vernakalant hydrochloride 60 sterile lidocaine patch 60 Novolimus 60 vernakalant 60 Firdapse 60 Thelin TM 60 FDA Approvable Letter 60 sumatriptan injection 60 Targeted Chemotherapy 60 FIRMAGON R 60 Zirgan 60 Augment TM 60 Hematide TM 60 candidate deforolimus 60 Vion Pharmaceuticals 60 ospemifene 60 novel oral anticoagulant 60 Romiplostim 60 non metastatic osteosarcoma 60 Zyflo CR 60 Vitrasert R 60 OMNARIS HFA 60 Elevess 60 NP2 Enkephalin 60 LibiGel Phase III 60 mocetinostat MGCD# 60 candidate AQ4N 60 Targretin 60 Tykerb lapatinib 60 Valtropin 60 bardoxolone 60 mapatumumab 60 M Enoxaparin 60 Maribavir 60 FOLOTYN 60 Pivotal Clinical Trial 60 chemotherapy induced neutropenia 60 ABSORB trial 60 Hepatitis C HCV 60 Rescula 60 Pafuramidine 60 Vertex hepatitis C 60 FLECTOR ® Patch 60 trospium 60 vapreotide acetate 60 topical gel 60 R PEG uricase 60 Market Approval PMA 60 Marketing Authorization Application 60 Somatuline Depot 60 Oral NKTR 60 ABILIFY ® 60 dexanabinol 60 Crofelemer budesonide foam 60 Retacrit 60 Intraject 60 JZP 6 60 Xeloda ® 60 Marketing Authorization Application MAA 60 Wyeth Progenics 60 Arcalyst 60 ocrelizumab 60 Diabetic Macular Edema 60 LightTouch 60 Behcet uveitis 60 Relistor 60 ancrod 60 Nascobal R 60 solanezumab 60 ThromCat 60 Ascend Therapeutics 60 Initiates Phase II 60 sBLA 60 Inhalation Aerosol 60 Efficacy Results 60 postoperative ileus POI 60 IND Investigational New 60 Chrysalin 60 COLAZAL R 60 Asentar TM 59 sNDA submission 59 prostone 59 CR# vcMMAE 59 topical NSAID 59 LibiGel transdermal testosterone gel 59 Diamyd R 59 BRIM2 59 Voraxaze ™ 59 Neovasc Reducer 59 Tiuxetan 59 bazedoxifene 59 TAXUS Liberte 59 Preotact R 59 Octreotide 59 Dificid 59 cintredekin besudotox 59 PFO migraine 59 etanercept Enbrel 59 refractory chronic lymphocytic 59 budiodarone 59 COLAZAL 59 sargramostim 59 TRO# 59 ALVESCO R 59 Technosphere Insulin 59 hypoxia activated prodrug 59 Azmacort 59 Increlex R 59 atacicept 59 rindopepimut 59 liposomal formulation 59 Infergen R 59 Acetavance TM intravenous acetaminophen 59 cancer neuroendocrine tumor 59 GLP1 agonist 59 isavuconazole 59 NSABP C 59 CAPHOSOL 59 rALLy trial 59 candidates bavituximab 59 Linjeta ™ 59 midstage clinical 59 eniluracil 59 Kuvan TM sapropterin 59 Altropane 59 candidate brentuximab vedotin 59 brentuximab vedotin SGN 59 GLP toxicology studies 59 refractory APL 59 phase 2a 59 MAXY VII 59 MyVax 59 brivaracetam 59 efficacy tolerability 59 TORISEL 59 delivery polymer matrix 59 REPLAGAL 59 granted Ortec 59 PROMUS Element 59 rALLy 59 CIP Fenofibrate 59 rPA anthrax vaccine 59 Aclasta Reclast 59 Somatuline R Depot 59 Diamyd ® 59 Gelclair 59 deforolimus 59 Vimpat R 59 Zenpep 59 iclaprim 59 Tarmogen 59 Oravig 59 dose intramuscular 59 Visudyne R 59 ULTRASE 59 tramiprosate Alzhemed TM 59 QLT# 59 RSD# 59 Hectorol R 59 DepoDur TM 59 Glassia 59 GRNVAC1 59 TRANSDUR ® 59 omega interferon 59 Phase 2b trial 59 velaglucerase alfa 59 Oracea ® 59 ELADUR ™ 59 ThermoDox R 59 tecarfarin 59 phase IIb III 59 Mipomersen 59 Catena ® 59 Ketotransdel TM 59 KRN# 59 phase III ACCLAIM 59 teriflunomide 59 Nanobody 59 ATPace TM 59 Trofex 59 vidofludimus 59 peginesatide 59 Feraheme ® 59 Nascobal Nasal Spray 59 miconazole Lauriad 59 DOS# 59 Ceplene histamine dihydrochloride 59 ZADAXIN ® 59 Abbokinase 59 histone deacetylase HDAC inhibitor 59 Adentri 59 recombinant thrombin 59 Neo Kidney Augment ™ 59 cancer immunotherapies 59 ALN TTR# 59 omalizumab Xolair 59 platforms GVAX 59 Phase IIIb 59 TAXUS Element Paclitaxel Eluting 59 Nanobody R 59 tramiprosate ALZHEMED TM 59 VIVITROL ® 59 Reclast Aclasta 59 luliconazole 59 BRIM3 59 Resten NG 59 Traficet EN 59 randomized Phase IIb 59 ATL/TV# 59 pain palliation 59 FIRAZYR 59 Gliadel Wafer 59 GSK# [002] 59 rasagiline tablets 59 AMEVIVE 59 Zemplar 59 LUCASSIN 59 vinorelbine tartrate 59 ostarine 59 Estrasorb 59 NAVISTAR R 59 Intarcia 59 HGS# 59 betrixaban 59 Iluvien TM 59 TRIOLEX HE# APOPTONE HE# 59 Phase 1b trial 59 Strativa 59 fund BioSante LibiGel 59 treatment naive genotype